Connection

Roy Gulick to HIV Infections

Back to Details
This is a "connection" page, showing publications Roy Gulick has written about HIV Infections.
Roy Gulick
Connection Strength
0.701
HIV Infections
  1. New HIV drugs: 2018 and beyond. Curr Opin HIV AIDS. 2018 07; 13(4):291-293.
    View in: PubMed
    Score: 0.119
  2. Investigational Antiretroviral Drugs: What is Coming Down the Pipeline. Top Antivir Med. 2018 Apr; 25(4):127-132.
    View in: PubMed
    Score: 0.117
  3. Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Women: A Phase 2 Randomized Trial. Ann Intern Med. 2017 Sep 19; 167(6):384-393.
    View in: PubMed
    Score: 0.112
  4. Antiretroviral treatment 2010: progress and controversies. J Acquir Immune Defic Syndr. 2010 Dec; 55 Suppl 1:S43-8.
    View in: PubMed
    Score: 0.070
  5. Durability of response to treatment among antiretroviral-experienced subjects: 48-week results from AIDS Clinical Trials Group Protocol 359. J Infect Dis. 2002 Sep 01; 186(5):626-33.
    View in: PubMed
    Score: 0.039
  6. The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies. J Infect Dis. 2018 11 05; 218(12):1954-1963.
    View in: PubMed
    Score: 0.030
  7. Combination therapy with anti-HIV-1 antibodies maintains viral suppression. Nature. 2018 09; 561(7724):479-484.
    View in: PubMed
    Score: 0.030
  8. Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals. Nat Med. 2018 11; 24(11):1701-1707.
    View in: PubMed
    Score: 0.030
  9. Relationship between latent and rebound viruses in a clinical trial of anti-HIV-1 antibody 3BNC117. J Exp Med. 2018 09 03; 215(9):2311-2324.
    View in: PubMed
    Score: 0.030
  10. Brain neurotransmitter transporter/receptor genomics and efavirenz central nervous system adverse events. Pharmacogenet Genomics. 2018 07; 28(7):179-187.
    View in: PubMed
    Score: 0.030
  11. A Conversation Among the IAS-USA Board of Directors: Hot Topics and Emerging Data in HIV Research and Care. Top Antivir Med. 2017 Dec/Jan; 24(4):142-151.
    View in: PubMed
    Score: 0.028
  12. Antibody 10-1074 suppresses viremia in HIV-1-infected individuals. Nat Med. 2017 Feb; 23(2):185-191.
    View in: PubMed
    Score: 0.027
  13. Novel clinical trial designs for the development of new antiretroviral agents. AIDS. 2012 May 15; 26(8):899-907.
    View in: PubMed
    Score: 0.019
  14. Vicriviroc resistance decay and relative replicative fitness in HIV-1 clinical isolates under sequential drug selection pressures. J Virol. 2012 Jun; 86(12):6416-26.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.